Estimating Cell Survival In Ac-225-PSMA Radionuclide Therapy Using PBPK Modeling, Monte Carlo Simulation, and the Two-Lesion Kinetic Model Considering Time-Dependent Dose Rate
This study aims to estimate prostate cancer cell survival following Ac-225-PSMA targeted radionuclide therapy by integrating physiologically based pharmacokinetic (PBPK) modeling, Monte Carlo simulations, and the two-lesion kinetic (TLK) radiobiological model...
Poster Program · Radiopharmaceuticals, Theranostics, and Nuclear Medicine